El-Tanani M, Satyam SM, Rabbani SA, El-Tanani Y, et al. Disruption of epidermal growth factor receptor signaling and cytoskeletal dynamics by mebendazole and gefitinib synergistically impairs paracrine cytokine signaling in non-small cell lung cancer and triple-negative breast cancer Cell lines. PLoS One 2025;20:e0338027.
PMID: 41401147